A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies

A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies

Patients with hematological malignancies have an increased risk of serious outcomes following COVID-19 infection, suggesting broader protection is needed beyond vaccination. Monoclonal antibodies such as sotrovimab, casirivimab–imdevimab, and bamlanivimab have provided valuable options for the treat...

Full description

Bibliographic Details
Main Authors: Carolyn Owen, Sue Robinson, Anna Christofides, Laurie H. Sehn
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Current Oncology
Subjects:
COVID-19
coronavirus
hematology
malignancy
Online Access:https://www.mdpi.com/1718-7729/29/6/315

Similar Items

Similar Items